SCHEMBL8495166

SCHEMBL8495166

CC(=O)C=C1CN(C(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
MEN1 O00255 1/20 0.50
CYP3A4 P08684 3/20 0.48
ALDH1A1 P00352 3/20 0.48
CYP2D6 P10635 3/20 0.48
CYP2C9 P11712 2/20 0.48
OPRD1 P41143 1/20 0.47
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MAOB P27338 1/20 0.45
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
DRD1 P21728 1/20 0.44
ADRA1D P25100 1/20 0.44
HTR2A P28223 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7260255 0.86 ALDH1A1 (0.51) KMT2AMEN1CYP3A4ALDH1A1CYP2D6
SCHEMBL15415069 0.82 CYP2D6 (0.48) KMT2AMEN1CYP3A4ALDH1A1CYP2D6
SCHEMBL71975 0.79 CTDSP1 (0.49) KMT2AMEN1OPRD1MAPTNPSR1
SCHEMBL17726461 0.79 KMT2A (0.50) KMT2AMEN1CYP3A4ALDH1A1CYP2D6
SCHEMBL4826291 0.75 OPRM1 (0.47) KMT2AMEN1CYP3A4ALDH1A1CYP2D6
SCHEMBL29785592 0.74 OPRM1 (0.46) KMT2AMEN1ALDH1A1CYP2D6OPRD1
SCHEMBL5280062 0.73 ALDH1A1 (0.54) KMT2AMEN1ALDH1A1OPRD1MAPT
SCHEMBL5280064 0.73 ALDH1A1 (0.54) KMT2AMEN1ALDH1A1OPRD1MAPT
SCHEMBL3131844 0.71 OPRM1 (0.44) KMT2AMEN1CYP3A4ALDH1A1CYP2D6
SCHEMBL20594076 0.71 KMT2A (0.57) KMT2AMEN1CYP3A4ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114763357-B Indolopyrimidine tricyclic compound and preparation method and application thereof 中国科学院上海药物研究所 2024-06-18 CN disclosed
US-5936088-A NERVOUS SYSTEM DISORDERS NOVO NORDISK A/S (DK) 1999-08-10 US disclosed
EP-0871627-A1 NOVEL SUBSTITUTED AZACYCLIC OR AZABICYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 1998-10-21 EP disclosed
WO-1997011073-A1 NOVEL SUBSTITUTED AZACYCLIC OR AZABICYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 1997-03-27 WO disclosed